Connective tissue diseases (CTDs) are a group of disorders characterized by abnormal immune system activity affecting the connective tissues throughout the body. These tissues include tendons, ligaments, skin, joints, and organs. Common CTDs include rheumatoid arthritis, systemic lupus erythematosus, and scleroderma. In CTDs, the immune system mistakenly attacks healthy tissues, leading to inflammation and tissue damage. Symptoms vary widely and may involve joint pain, skin rashes, fatigue, and internal organ complications. Treatment aims to manage symptoms and control inflammation, typically utilizing medications such as corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and immunosuppressants. Multidisciplinary care involving rheumatologists, dermatologists, and other specialists is crucial for comprehensive management. Early detection and intervention play a key role in improving outcomes and enhancing the quality of life for individuals affected by connective tissue diseases.
Title : Selective denervation for persistent knee pain after total knee arthroplasty: Long-term outcomes
Shaomin Shi, Medical College of Wisconsin, United States
Title : The effect of OTC N-acetyl-cysteine on cobaltemia and cobalturia from cobalt-chromium orthopedic implants
Stephen S Tower, University of Alaska Anchorage, United States
Title : Sports medicine pearls of the foot and ankle
Matthew B Werd, American Academy of Podiatric Sports Medicine (AAPSM), United States
Title : Safety and efficacy of distraction osteogenesis for height dysphoria
Dimitrios Giotikas, LIPS Battersea Healthcare, United Kingdom
Title : AI-Driven infrared imaging and telerobotics in orthopedics: Enhancing diagnostics, surgical precision, and postoperative care
Marcos Brioschi, American Academy of Thermology, United States
Title : Revolutionizing orthopedics: The future of biomechanics through artificial intelligence
Moataz Eltoukhy, University of Miami, United States